Profund Advisors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
64,771
+9,576
| +17% | +$174K | 0.04% | 264 |
|
|
2025
Q1 | $1.1M | Sell |
55,195
-51,232
| -48% | -$1.02M | 0.05% | 276 |
|
|
2024
Q4 | $1.83M | Buy |
106,427
+20,215
| +23% | +$347K | 0.07% | 193 |
|
|
2024
Q3 | $1.72M | Buy |
86,212
+32,029
| +59% | +$640K | 0.07% | 216 |
|
|
2024
Q2 | $606K | Sell |
54,183
-53,803
| -50% | -$602K | 0.02% | 442 |
|
|
2024
Q1 | $713K | Buy |
107,986
+16,913
| +19% | +$112K | 0.03% | 456 |
|
|
2023
Q4 | $412K | Sell |
91,073
-16,080
| -15% | -$72.7K | 0.02% | 619 |
|
|
2023
Q3 | $384K | Sell |
107,153
-24,556
| -19% | -$87.9K | 0.02% | 549 |
|
|
2023
Q2 | $486K | Sell |
131,709
-50,704
| -28% | -$187K | 0.03% | 522 |
|
|
2023
Q1 | $604K | Buy |
+182,413
| New | +$604K | 0.04% | 450 |
|